Phenylpiracetam: The Most Stimulating Racetam (2026)

Phenylpiracetam — also known by its Russian trade names Phenotropil and Carphedon — is what happens when a chemist adds a phenyl group to the piracetam molecule and the resulting compound turns out to be categorically different from its parent. That single structural modification transformed a mildly stimulating cognitive enhancer into the most energizing, performance-boosting compound in the racetam family: potent enough that the World Anti-Doping Agency banned it for competitive athletes, a distinction no other racetam has earned.

Developed at the Russian Academy of Medical Sciences in the 1980s and later adopted by the Russian space program and military for performance under extreme conditions, phenylpiracetam was primarily a clinical compound for most of its existence. Russian physicians prescribed it for cognitive rehabilitation, fatigue, and depression. Western awareness came slowly — and then accelerated sharply when the nootropics community discovered that phenylpiracetam delivered immediate, first-dose stimulation unlike anything else in the racetam class. By the late 2010s it was widely discussed in nootropics forums as the go-to option for demanding days requiring both cognitive and physical performance.

The manufacturer (JSC LEKKO Pharmaceuticals, the same company behind noopept) discontinued production of the original Phenotropil brand in 2017, citing changes in Russian pharmaceutical regulations. The compound itself remains widely available from research chemical vendors globally. This guide covers everything you need to know to use it effectively.

How Phenylpiracetam Works

The phenyl group addition to piracetam's structure dramatically alters the compound's pharmacological profile and, crucially, its ability to cross the blood-brain barrier. The parent piracetam molecule crosses relatively poorly; phenylpiracetam's increased lipophilicity allows significantly more efficient CNS penetration, which partly explains the substantially lower effective dose (100–200mg versus piracetam's 1200–4800mg).

Unlike most racetams, which work primarily through AMPA glutamate receptor modulation and membrane fluidity effects, phenylpiracetam has a demonstrably broader receptor profile that explains its stimulant-like properties. Animal studies have shown that phenylpiracetam increases the density of dopamine receptors (D1 and D2) in the brain — an effect distinct from the mechanism of amphetamines, which flood the synapse with dopamine rather than upregulating receptor availability. This receptor density increase may explain why phenylpiracetam's cognitive and motivational effects feel different from traditional stimulants: sharper and cleaner, with less of the jitteriness or anxiety that accompanies high-dopamine-release drugs.

Phenylpiracetam also interacts with GABA receptors, particularly GABA-A receptor subtypes, in ways that differ from the standard racetam class. This interaction may contribute to its anti-anxiety properties and to the sense of confident, focused arousal that users describe — a state distinct from raw dopaminergic stimulation. Additionally, phenylpiracetam retains the classic racetam effects on AMPA glutamate receptors and acetylcholine neurotransmission that give the entire family its cognitive-enhancing character.

The physical performance effects — increased stamina, reduced fatigue perception, improved cold tolerance — that prompted WADA to ban phenylpiracetam are thought to involve dopaminergic and noradrenergic mechanisms in motor cortex and subcortical motor circuits, combined with effects on the hypothalamic thermoregulatory system that explain the cold tolerance finding specifically. Russian cosmonauts reportedly used it to maintain performance during extravehicular activities in the thermal extremes of space.

Benefits

Phenylpiracetam's benefit profile is broader than most nootropics, spanning cognitive, motivational, and physical domains. Unlike the gradual, cumulative benefits of noopept or piracetam, phenylpiracetam's effects are acute and apparent on the first dose.

Cognitive stimulation is the primary draw for most users. Mental alertness sharpens noticeably within an hour of dosing. Tasks that would normally require significant activation energy — starting complex work, maintaining focus through lengthy projects, rapid information processing — feel more accessible. The quality is often described as a "switched on" mental state without the nervous energy or anxiety that stimulants like Adderall can produce.

Physical performance enhancement is genuinely distinctive. Endurance improves, fatigue onset is delayed, and physical tasks feel less effortful. WADA's decision to ban phenylpiracetam was based on documented performance improvements in competitive athletes, not precautionary principle. For non-athletes, this translates to more physical energy throughout the day and the ability to sustain demanding activity longer.

Motivation and drive are reliably enhanced. The dopaminergic activity generates genuine goal-directed motivation rather than the scattered hyperactivity of high-dose stimulants. Users report stronger initiative, willingness to tackle difficult tasks, and reduced procrastination.

Cold tolerance is a specific and well-documented effect with its origins in the Russian space and military research context. Users in cold climates report noticeably reduced sensitivity to cold on phenylpiracetam days — an oddly specific benefit that has been cited as evidence of phenylpiracetam's genuine pharmacological activity by skeptics who would otherwise dismiss nootropic claims.

Anti-amnesic properties align with the broader racetam family's memory-protective effects. Phenylpiracetam has shown ability to reverse memory impairment in animal models of amnesia and cognitive dysfunction.

Mood elevation is commonly reported. Not euphoria — phenylpiracetam does not produce a dopamine flood — but a stable upward shift in baseline mood and confidence that persists through the duration of the dose.

Dosage

Phenylpiracetam dosing requires more restraint than most nootropics because of its rapid tolerance development. The pharmacological principle here is important: the more frequently you use it, the less effective it becomes. Unlike modafinil or caffeine, which maintain effectiveness with daily use, phenylpiracetam is best treated as a high-value, selective-use tool.

Effective dose range: 100–200mg per day. Most users find 100mg sufficient for clear stimulant and cognitive effects, particularly when not yet habituated. Starting at 100mg is the sensible approach. The 200mg dose is appropriate for demanding days when maximum effect is required, but should not be the default.

Frequency: Maximum 2–3 times per week. At least one full day between doses is the minimum; many experienced users space doses every 3–4 days to maintain full potency. The development of tolerance to phenylpiracetam is among the fastest in the nootropics world — consecutive daily use for even 3–5 days significantly blunts the effect. A weekend break is not sufficient recovery for heavy weekly users.

Timing: Take in the morning, with or without food. The stimulant properties make afternoon or evening dosing inadvisable — insomnia is a reliable consequence of late dosing. Phenylpiracetam's half-life is approximately 3–5 hours, so morning dosing allows effects to wear off before sleep while covering the most productive hours of the day.

Choline supplementation: As with all racetams, pairing with a choline source (citicoline 250–500mg or alpha-GPC 150–300mg) prevents cholinergic depletion headaches and enhances cognitive effects. This is not optional for multi-dose use.

Avoid daily use under any circumstances. Users who attempt to use phenylpiracetam daily consistently report that within a week they are taking it for no effect at all. Preserving its potency requires genuine restraint — it is the compound that most rewards a disciplined dosing schedule. For further reading on phenylpiracetam tolerance and cycling protocols, NootroBlog's guide goes into additional detail on spacing strategies that experienced users have settled on.

Phenylpiracetam vs Modafinil

Both phenylpiracetam and modafinil provide wakefulness, cognitive stimulation, and enhanced motivation, and both are commonly used by the same population of productivity-focused individuals. But the comparison reveals important differences that determine which is the better choice for a given context.

The practical conclusion: modafinil is the better daily driver for cognitive productivity due to its longer duration, lower tolerance risk, and smoother profile. Phenylpiracetam is the better choice for demanding, specific days when you need both cognitive sharpness and physical performance — workouts, high-stakes presentations, physically demanding work. Many users maintain both in their toolkit and deploy each in its appropriate context.

Phenylpiracetam vs Other Racetams

Within the racetam family, phenylpiracetam sits in its own category. Understanding where it fits helps you choose the right compound for a given goal.

Piracetam (the original): Mild cognitive enhancement, memory support, membrane fluidity effects. Very gradual onset, requires weeks of use for full effect. No stimulant properties. Low-risk daily use for months. Think of piracetam as a cognitive maintenance tool, not a performance booster.

Aniracetam: Anxiolytic and mood-enhancing more than stimulating. Useful for social situations, creative work, or contexts where reducing anxiety is the goal. Fat-soluble, so must be taken with food. No physical stimulation.

Oxiracetam: Provides mild cognitive stimulation — more than piracetam, but nothing close to phenylpiracetam. Often described as improving logical thinking and verbal fluency. Some users use it as a modest energy lift without the intensity or tolerance concerns of phenylpiracetam.

Phenylpiracetam: Unambiguously the most stimulating, physically energizing, and acutely performance-enhancing of the group. Its dopaminergic mechanism and physical performance effects set it apart. The cost: rapid tolerance requires strict cycling discipline.

For a deep dive on noopept — a peptide-derived compound that works differently from all of these — see our complete noopept guide.

Side Effects

Phenylpiracetam is generally well-tolerated at 100–200mg taken 2–3 times per week. Side effects are dose-dependent and significantly more likely with frequent use.

Headaches are the most common complaint, arising from acetylcholine depletion — the same mechanism responsible for headaches with piracetam and noopept. Consistent choline supplementation prevents this in the majority of users. If headaches persist despite choline intake, reducing the dose is the next step.

Insomnia is reliably produced by afternoon or evening dosing. The stimulant activity persists for 4–6 hours after the peak, meaning a 3pm dose often interferes with sleep at 11pm. Morning-only dosing eliminates this issue for most users.

Irritability and emotional reactivity can emerge at higher doses (200mg+) or with more frequent use than the recommended 2–3 times per week. The dopaminergic stimulation becomes less clean and more edgy as tolerance develops and doses increase. Reducing frequency typically resolves this.

Rapid tolerance is arguably the most significant practical side effect — not a health concern, but a limitation that undermines the compound's value if not managed. Users who ignore the cycling recommendation consistently find phenylpiracetam stops working after a week of daily use. Recovery requires a break of at least 1–2 weeks.

There are no known serious adverse effects at recommended doses in healthy individuals. Phenylpiracetam is not hepatotoxic, does not produce physical dependence, and has no documented withdrawal syndrome. Its safety profile in the 100–200mg, 2–3x/week context is favorable.

Legal Status

Phenylpiracetam occupies a legally permissive position in most jurisdictions for personal use, despite its WADA prohibition status — these are entirely separate regulatory frameworks.

In the United States, phenylpiracetam is neither FDA-approved nor scheduled under the Controlled Substances Act. It is sold legally as a research compound and purchased by thousands of individuals for personal use. Importing reasonable quantities for personal use is generally not prosecuted, though it exists in a regulatory gray zone.

In the United Kingdom, phenylpiracetam is not listed under the Misuse of Drugs Act and is not regulated as a medicine unless marketed with therapeutic claims. The Psychoactive Substances Act (2016) does not apply to cognitive enhancers. Personal possession and purchase are not offenses.

In Russia, phenylpiracetam was a registered prescription pharmaceutical (Phenotropil) until production was discontinued in 2017. It is no longer manufactured by the original developer and is not available as a prescription product, though Russian regulatory frameworks for research compounds are complex.

For competitive athletes subject to anti-doping testing: phenylpiracetam is explicitly prohibited under WADA's Prohibited List in the Stimulants category (S6). It is also prohibited by most national and international sports federations that adopt the WADA code. Testing positive carries the standard doping violation consequences. Any athlete subject to anti-doping rules should avoid phenylpiracetam entirely.

Where to Buy

Following the discontinuation of original Phenotropil, phenylpiracetam is available almost exclusively through online research compound vendors. As with noopept and other unregulated nootropics, quality control is the primary concern — third-party lab testing is the only reliable way to verify that what you are purchasing is what it claims to be.

Look for vendors providing certificates of analysis (COA) from independent laboratories, with assay purity values and confirmation of identity by HPLC or NMR. Reputable vendors in the nootropics space have maintained these standards consistently. Avoid powder or capsule products without documented testing — the stakes are higher with a compound that is active at 100–200mg and for which precise dosing matters.

For guidance on purchasing smart drugs online safely, see Buying Smart Drugs Online.

Frequently Asked Questions